Professor Tore Bengtsson is awarded a SEK 2 million grant from Diabetes Wellness Sverige

Tore Bengtsson and his group at the Department of Molecular Biosciences, The Wenner-Gren Institute, have been awarded a SEK 2 million grant from Diabetes Wellness Sverige for their research on a new treatment of type 2 diabetes.

The grant is awarded the project "Novel selectively targeted stimulation of the β2-adrenoceptor for the treatment of type 2 diabetes", in which Tore Bengtsson and his group introduce a new way for the body to control its blood sugar levels.

The novel method helps the body to lower its blood sugar levels by stimulating a cellular receptor called the β2-adrenoceptor (β2-AR) in a new way. This has the potential to lead to the development of new drugs, and to revolutionize how doctors treat diabetes.

Read more (in Swedish)

Theme

Research subject

Integrative biology

Research group

Group Bengtsson

Obesity is a major inducer of type II diabetes and it is estimated by the World Health Organization that over 500 million people worldwide suffer from either of these disorders, with the incidence increasing dramatically over the last 10 years.

Last updated: May 23, 2023

Source: MBW